protoporphyrin ix has been researched along with Esophageal Neoplasms in 15 studies
protoporphyrin IX: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7685
protoporphyrin : A cyclic tetrapyrrole that consists of porphyrin bearing four methyl substituents at positions 3, 8, 13 and 17, two vinyl substituents at positions 7 and 12 and two 2-carboxyethyl substituents at positions 2 and 18. The parent of the class of protoporphyrins.
Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Four patients with known gastric adenoma (n = 1), macroscopically undetected but histologically proven esophageal squamous cell cancer (n = 1), suspected early cancer of the esophagus (n = 1), and multiple duodenal adenomas (n = 1) were sensitized with 5-aminolevulinic acid administered orally (15 mg/kg body weight)." | 3.70 | Endoscopic photodynamic diagnosis: oral aminolevulinic acid is a marker of GI cancer and dysplastic lesions. ( Hahn, EG; Hochberger, J; Mayinger, B; Reh, H, 1999) |
| "Preliminary studies in early esophageal cancer also show effectiveness." | 2.41 | Photodynamic therapy for esophageal cancer. Update. ( Greenwald, BD, 2000) |
| "Barrett's esophagus is strongly associated with adenocarcinoma." | 1.32 | Endoscopic fluorescence detection of intraepithelial neoplasia in Barrett's esophagus after oral administration of aminolevulinic acid. ( Dorta, G; Felley, C; Fontolliet, C; Gabrecht, T; Grosjean, P; Jornod, P; Lange, N; Monnier, P; Stepinac, T; van den Bergh, H; vanMelle, G; Wagnières, G, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yeh, SC | 1 |
| Sahli, S | 1 |
| Andrews, DW | 1 |
| Patterson, MS | 1 |
| Armstrong, D | 1 |
| Provias, J | 1 |
| Fang, Q | 1 |
| Chen, X | 1 |
| Zhao, P | 1 |
| Chen, F | 1 |
| Li, L | 1 |
| Luo, R | 1 |
| Brand, S | 1 |
| Wang, TD | 1 |
| Schomacker, KT | 1 |
| Poneros, JM | 1 |
| Lauwers, GY | 1 |
| Compton, CC | 1 |
| Pedrosa, MC | 1 |
| Nishioka, NS | 1 |
| Ortner, MA | 1 |
| Ebert, B | 1 |
| Hein, E | 1 |
| Zumbusch, K | 1 |
| Nolte, D | 1 |
| Sukowski, U | 1 |
| Weber-Eibel, J | 1 |
| Fleige, B | 1 |
| Dietel, M | 1 |
| Stolte, M | 1 |
| Oberhuber, G | 1 |
| Porschen, R | 1 |
| Klump, B | 1 |
| Hörtnagl, H | 1 |
| Lochs, H | 2 |
| Rinneberg, H | 1 |
| Stepinac, T | 1 |
| Felley, C | 1 |
| Jornod, P | 1 |
| Lange, N | 1 |
| Gabrecht, T | 1 |
| Fontolliet, C | 1 |
| Grosjean, P | 1 |
| vanMelle, G | 1 |
| van den Bergh, H | 1 |
| Monnier, P | 1 |
| Wagnières, G | 1 |
| Dorta, G | 1 |
| Ji, Z | 1 |
| Yang, G | 1 |
| Vasovic, V | 1 |
| Cunderlikova, B | 1 |
| Suo, Z | 1 |
| Nesland, JM | 1 |
| Peng, Q | 1 |
| Ortner, M | 1 |
| Messmann, H | 2 |
| Knüchel, R | 1 |
| Endlicher, E | 1 |
| Hauser, T | 1 |
| Szeimies, RM | 1 |
| Kullmann, F | 1 |
| Bäumler, W | 1 |
| Schölmerich, J | 1 |
| Mĺkvy, P | 1 |
| Regula, J | 1 |
| Conio, M | 1 |
| Pauer, M | 1 |
| Millson, CE | 1 |
| MacRobert, AJ | 1 |
| Bown, SG | 1 |
| Hinnen, P | 2 |
| de Rooij, FW | 2 |
| van Velthuysen, ML | 1 |
| Edixhoven, A | 2 |
| van Hillegersberg, R | 2 |
| Tilanus, HW | 2 |
| Wilson, JH | 2 |
| Siersema, PD | 2 |
| Mayinger, B | 2 |
| Reh, H | 2 |
| Hochberger, J | 1 |
| Hahn, EG | 2 |
| Terlouw, EM | 1 |
| van Dekken, H | 1 |
| Greenwald, BD | 1 |
| Neidhardt, S | 1 |
| Martus, P | 1 |
| Pech, O | 1 |
| Nagy, CD | 1 |
| Gossner, L | 1 |
| May, A | 1 |
| Ell, C | 1 |
1 review available for protoporphyrin ix and Esophageal Neoplasms
| Article | Year |
|---|---|
Photodynamic therapy for esophageal cancer. Update.
Topics: Animals; Barrett Esophagus; Dihematoporphyrin Ether; Esophageal Neoplasms; Humans; Photochemotherapy | 2000 |
1 trial available for protoporphyrin ix and Esophageal Neoplasms
| Article | Year |
|---|---|
Photodynamic therapy for gastrointestinal tumors using three photosensitizers--ALA induced PPIX, Photofrin and MTHPC. A pilot study.
Topics: Adult; Aged; Aminolevulinic Acid; Dihematoporphyrin Ether; Duodenal Neoplasms; Esophageal Neoplasms; | 1998 |
13 other studies available for protoporphyrin ix and Esophageal Neoplasms
| Article | Year |
|---|---|
5-Aminolevulinic acid induced protoporphyrin IX as a fluorescence marker for quantitative image analysis of high-grade dysplasia in Barrett's esophagus cellular models.
Topics: Adenocarcinoma; Algorithms; Aminolevulinic Acid; Barrett Esophagus; Biomarkers; Esophageal Neoplasms | 2015 |
Effect and mechanism of 5-aminolevulinic acid-mediated photodynamic therapy in esophageal cancer.
Topics: Aminolevulinic Acid; Animals; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Prolifer | 2011 |
Detection of high-grade dysplasia in Barrett's esophagus by spectroscopy measurement of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett Esophagus; Esophageal Neoplasms; Esopha | 2002 |
Time gated fluorescence spectroscopy in Barrett's oesophagus.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett Esophagus; Biomarkers, | 2003 |
Endoscopic fluorescence detection of intraepithelial neoplasia in Barrett's esophagus after oral administration of aminolevulinic acid.
Topics: Administration, Oral; Adult; Aged; Aminolevulinic Acid; Barrett Esophagus; Carcinoma in Situ; Esopha | 2003 |
Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines.
Topics: Adenosine Triphosphate; Aminolevulinic Acid; Carcinoma, Squamous Cell; Cell Line; Cell Line, Tumor; | 2006 |
[Eradication of high-grade dysplasia in Barrett esophagus by photodynamic therapy with endogenously generated protoporphyrin IX].
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett Esophagus; Esophageal Neoplasms; Esophagus; Fe | 1998 |
[Photodynamic diagnosis of gastrointestinal precancerous lesions after sensitization with 5-aminolevulinic acid. A pilot study].
Topics: Adenoma; Adult; Aged; Aminolevulinic Acid; Barrett Esophagus; Colitis, Ulcerative; Colorectal Neopla | 1998 |
Biochemical basis of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation: a study in patients with (pre)malignant lesions of the oesophagus.
Topics: Adult; Aged; Aminolevulinic Acid; Barrett Esophagus; Esophageal Neoplasms; Esophagus; Female; Ferroc | 1998 |
Endoscopic photodynamic diagnosis: oral aminolevulinic acid is a marker of GI cancer and dysplastic lesions.
Topics: Adenoma; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Duodenal Neoplasms; Endoscopy, Digesti | 1999 |
Porphyrin biosynthesis in human Barrett's oesophagus and adenocarcinoma after ingestion of 5-aminolaevulinic acid.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Barrett E | 2000 |
Fluorescence induced with 5-aminolevulinic acid for the endoscopic detection and follow-up of esophageal lesions.
Topics: Administration, Oral; Aged; Aminolevulinic Acid; Biopsy; Esophageal Neoplasms; Esophagoscopy; Female | 2001 |
Photodynamic therapy of human Barrett's cancer using 5-aminolaevulinic acid-induced protoporphyrin IX: an in-vivo dosimetry study in athymic nude mice.
Topics: Adenocarcinoma; Aminolevulinic Acid; Animals; Barrett Esophagus; Esophageal Neoplasms; Humans; Mice; | 2002 |